2 天前 - … of the class of cholesterol lowering drugs called statins, which … Statins are used to
reduce the risk of cardiovascular … or a history of cardiovascular disease. While atorvastatin is …

4 天前 - … reduction of cardiovascular events is the reduction in inflammation [3]. Therefore, the
reduction in … , which is made manifest in a decrease in the CRP level, although statistically …

5 天前 - … that statins may be associated with reduced risk of venous … the comparative effect
of all lipid-lowering therapies (LLT) … results regarding cardiovascular event reduction, was not …

6 天前 - … other cardiac events like arrythmias or sudden cardiac death … an effect of the
intervention of 30% risk reduction translate to … risk markers and lipid- lowering agents in the …

6 天前 - Chronic obstructive pulmonary disease (COPD) is the third-leading cause of death
globally following ischaemic heart disease and stroke. 1 Cardiovascular disease (CVD) is …

6 天前 - … of gout as compared to standard lipidlowering therapies. … includes lipid-lowering
therapies which specifically target the LDL-C to reduce cardiovascular events, and thus statins …

6 天前 - … and degenerative valvular heart diseases, particularly with … lipid-lowering therapies
with high efficacy in reducing … , the effects of this reduction on cardiovascular outcomes are …

6 天前 - … of patients with established cardiovascular disease (CVD), aspirin resulted in a 15%
reduction in vascular mortality and a 30% reduction … intensive lipid-lowering therapies and …

7 天前 - … effect of statins on TAA growth rate. In particular, patients under statin treatment
showed a reduced … ) compared with controls, patients that did not take statins. Regarding the …

7 天前 - … at high risk of atherosclerotic cardiovascular disease (ASCVD), … with lipid-lowering
treatment were initiated in patients … There was a significant reduction in LDL-C from baseline …